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Edited by Ned ManteiAbstract Three methylated bases, 5-methylcytosine, N4-meth-
ylcytosine and N6-methyladenine (m6A), can be found in
DNA. However, to date, only 5-methylcytosine has been
detected in mammalian genomes. To reinvestigate the presence
of m6A in mammalian DNA, we used a highly sensitive method
capable of detecting one N6-methyldeoxyadenosine per million
nucleosides. Our results suggest that the total mouse genome
contains, if any, less than 103 m6A. Experiments were next
performed on PRED28, a putative mammalian N6-DNA methyl-
transferase. The murine PRED28 encodes two alternatively
spliced RNA. However, although recombinant PRED28 proteins
are found in the nucleus, no evidence for an adenine-methyltrans-
ferase activity was detected.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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In mammalian DNA, the crucial function of cytosine meth-
ylation in chromatin structure and gene functions has led to
the consideration of 5-methylcytosine (m5C) as the ﬁfth base
of DNA [1,2]. In addition to m5C, there are two other known
methylated bases, N6-methyladenine (m6A) and N4-methylcy-
tosine (m4C). However, m6A and m4C are generally consid-
ered to be speciﬁc to bacterial or protist DNA [3], and have
not yet been identiﬁed in mammalian DNA. In prokaryotes,
the function of m4C and m5C seems to be limited to restric-
tion-modiﬁcation systems [4], although m5C is also part of
the very short-patch repair system [5]. On the contrary, the
biological role of m6A in bacteria is more widespread, and in-
cludes postreplicative DNA mismatch repair, chromosome
compaction and regulation of gene expression [4]. Moreover,
adenine methylation is essential for the virulence or viability
of several pathogenic bacterial strains [6–8]. This suggests that
bacterial N6-DNA methyltransferase is a potential target for
the design of new antimicrobial agents [9]. The interest for this*Corresponding author. Fax: +33 4 76 76 56 19.
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mining the existence of N6-DNA methyltransferases in higher
eukaryotes.
The current assumption that m5C is the only methylated
base present in animal DNA relies on experiments performed
about thirty years ago with a detection limit of around
0.01% [10–12]. However, even if analytical methods failed to
detect m6A in mammalian DNA, indirect evidence based on
restriction enzyme analyses has suggested the presence of
m6A in the mouse myogenic and the rat type 2 steroid 5a-
reductase genes [13,14]. Hence, current analytical methods
are suﬃcient to detect m5C in mammalian DNA (approxi-
mately 1–6%), but may be inadequate to detect the possible
presence of a few hundred m6A in the 3.3 · 109 bases of the
Homo sapiens genome [15]. This suggests that the methylation
status of adenine in mammalian DNA could be similar to the
situation encountered a few years ago with cytosine methyla-
tion in Drosophila melanogaster. Indeed, it had been well-ac-
cepted that DNA from D. melanogaster was not methylated,
a belief recently challenged by the presence of m5C in this spe-
cies [16]. In this regard, the recent characterization of a
N6-adenine DNA methyltransferase from wheat coleoptiles
suggests the occurrence of adenine methylation in higher
eukaryotes [17].
A prerequisite for the presence of m6A in mammalian DNA
is the expression of a N6-DNA methyltransferase. In silico
analyses of mouse and human genomes have identiﬁed the
existence of the PRED28 gene that encodes a putative N6-
DNA methyltransferase (http://harvester.embl.de/harvester/
Q9Y5/Q9Y5N5.htm; GenBank gene ID: 29104). This gene is
located on human chromosome 21 or mouse chromosome
16, two chromosomes syntenic for this region. This situation
prompted us to reexamine the methylation status of adenine
in mammalian DNA.2. Materials and methods
2.1. Bacterial strains
Escherichia coli TOP10 (Invitrogen) was used for transformation
procedures and maintenance of plasmids. E. coli GM 272 (dam,
dcm, hsdS) [18] was used for expression studies. This strain has
mutations in genes encoding the adenine DNA methyltransferases
and is therefore expected to have very little m6A in its DNA.blished by Elsevier B.V. All rights reserved.
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DNA analysis: Genomic DNA was extracted using the Genomic
DNA buﬀer set and Qiagen Genomic Tip from Qiagen (Qiagen, Cour-
taboeuf, France). Human placental mitochondria were puriﬁed as de-
scribed [19]. Mitochondrial DNA was extracted using the QIAamp
DNA kit from Qiagen (Qiagen, Courtaboeuf, France). Subsequently,
genomic or mitochondrial DNA was incubated with a mixture of endo-
and exonucleases, and alkaline phosphatase that quantitatively liberate
N6-methyldeoxyadenosine (MedAdo) [20]. This was demonstrated
using plasmid DNA that contained a known amount of MedAdo. A
HPLC-electrospray ionization tandem mass spectrometry (HPLC–
MS/MS) method has been developed for the detection of MedAdo, as
previously described for the measurement of oxidized nucleosides
[21,22]. The HPLC-MS/MS system used for the detection of MedAdo
has been previously described [23]. The limits of sensitivity (S/N = 3)
for the assay were close to 20 fmol of injected MedAdo (corresponding
to a concentration of 0.5 nM). Quantiﬁcation was performed by exter-
nal calibration, and the amount of DNA was determined by UV
absorption using the peak of deoxyguanosine [22].2.3. RNA puriﬁcation and reverse transcription (RT)-PCR
Total RNA extraction and RT-PCR were performed using the
Rneasy and Qiagen OneStep RT-PCR kits (Qiagen, Courtaboeuf,
France). Oligonucleotide primers were designed based on the mouse
PRED28 cDNA sequence available in the GenBankTM data base under
Accession AY456393. The oligonucleotides used were PRED1a 5 0-
GTGCGTACTCAACGCCCGCCCATAGG-30 (forward) and PRED1b
50-GCTGCCGGCAGCTCTTGTTTACTTCTGTGG (reverse). Geno-
mic DNA contamination was controlled by PCR of non-reverse tran-
scribed RNA.Table 1
Content of MedAdo in the DNA of diﬀerent mouse tissues or cells
Source of DNA MedAdo/106
nucleosides
Heart <1
Muscle <1
Liver <1
Brain <12.4. Cloning of PRED28 splice variants
The coding regions of PRED28a and PRED28b were ampliﬁed by
RT-PCR from embryonic mouse brain mRNA and cloned into
pcDNA3.1/V5His-TOPO (Invitrogen) to generate pcDNA3/PRED28a
and pcDNA3/PRED28b. Primers used for PRED28a ampliﬁcation
are 5 0-GCGGAAGGGAAAAGATGGCGGCGCC-3 0 (forward) and
50-GAGGGACTTGCTGAACCTGAGGACTGACAGG-30 (reverse).
Primers used for PRED28b are 5 0-GCGGAAGGGAAAAGATGG-
CGGCGCC-3 0 (forward) and 5 0-CAATTGTTTTAAAGATTTCCT-
CTCAG-3 0 (reverse). The cDNA sequence of PRED28a corresponds
to the sequence of the Mus musculus N6-DNA methyltransferase
mRNA in GenBank under Accession AY456393, whereas the cDNA
sequence of PRED28b corresponds to a new transcript variant depos-
ited under Accession AY536887. The full-length coding regions of
pcDNA3/PRED28a and pcDNA3/PRED28b were ampliﬁed with the
primers 5 0-GGGGTACCGAGCTCGGATCCACTAG-3 0 (forward)
and 5 0-CACGGGGGATCCGCAAACAACAGATGGCTGGCAAC-
3 0 (reverse) and subcloned in the BamHI site of the eukaryotic expres-
sion vector pcDNA4/TO (Invitrogen) to generate pcDNA4/PRED28a
and pcDNA4/PRED28b. To express PRED28 isoforms in E. coli, the
coding regions of the two isoforms of PRED28 were ampliﬁed and
cloned under the control of the araBAD promoter in the bacterial
expression vector pBAD-TOPO (Invitrogen) to generate pBAD/PRE-
D28a and pBAD/PRED28b. The primers used for PRED28a ampliﬁ-
cation were 5 0-GCGGCGCCGAGTGTCCCCACGCCG-3 0 (forward)
and 5 0-GAGGAATAATAAATGGCGGCGCCGAGTGTCCCCAC-
GCCG-3 0 (reverse), and the primers used for PRED28b are
5 0-GCGGCGCCGAGTGTCCCCACGCCG-3 0 (forward) and 50-
TAATAAATGGCGGCGCCGAGTGTCCCCACG-30 (reverse). All
the resulting recombinant proteins contain a C-terminal V5 epitope
tag and a C-terminal 6 · His tag. All the constructs were veriﬁed by
DNA sequencing.Testis <1
Brain <1
Mitochondria <1
C2C12 <1
C2C12-Pred a <1
C2C12-Pred b <1
E. coli GM272-PREDa non-induced (n = 3) 38.4 ± 10.5
E. coli GM272-PREDa induced (n = 3) 35.1 ± 9.6
E. coli GM272-PREDb non-induced (n = 2) 44.1 ± 3.9
E. coli GM272-PREDb induced (n = 3) 35.2 ± 4.22.5. Cell culture and transfection
C2C12 cells were grown to approximately 80% conﬂuence, and
transfection was performed by incubating C2C12 cells with either
pcDNA4/PRED28a or pcDNA4/PRED28b vector using the Lipofect-
amine 2000 reagent according to the manufacturer’s instructions
(Invitrogen). For selection of stable recombinant clones, zeocin
(100 lg/ml) was added 72 h after transfection. Expression was veriﬁed
by immunoﬂuorescence staining and Western blot using a V5 antibody
(Invitrogen).2.6. Bacterial expression of recombinant PRED28
For the bacterial expression of recombinant proteins, E. coli GM272
clones harboring either pBAD/PRED28a or pBAD/PRED28b were
grown at 37 C in LB broth containing Amp to an OD600 of 0.25.
At this point the cultures were split, and L-arabinose (0.1% ﬁnal con-
centration) was added to one of the cultures to induce protein produc-
tion. After 1 h, the bacteria were centrifuged and processed for either
DNA extraction or for Western blot analysis. For Western blot anal-
ysis, cell pellets were resuspended and lysed in CelLytic buﬀer (Sig-
ma). Then, cell lysates were centrifugated at 18000 · g for 15 min to
pellet the insoluble material. Western blot analyses were performed
on both the supernatant and insoluble fractions using a V5 antibody
(Invitrogen). For DNA analysis, DNA was extracted using the DNA
genomic buﬀer set from Qiagen according to the manufacturer’s
instructions.3. Results
3.1. Determination of m6A content in mammalian and
mitochondrial DNA
Previous base analyses of mammalian DNA have failed to
detect the presence of m6A. However, these analyses were per-
formed over twenty years ago with a detection threshold
around 0.01%. Therefore, in an attempt to reexamine the prob-
lem of adenine methylation in mammalian DNA, we have
developed an extremely sensitive assay for MedAdo with a
detection threshold of one MedAdo per 106 nucleosides. How-
ever, even using this sensitive assay we were unable to detect
adenine methylation in the nuclear DNA of several mouse tis-
sues (Table 1). According to the size of the mouse genome
(2.5 Gb), these results suggest that the total mouse genome
contains less than 2.5 · 103 m6A. In addition, since it has been
suggested that mitochondria could be the degenerate descen-
dants of endosymbiotic bacteria, and since bacterial DNA is
known to contain m6A, mitochondrial DNA from human pla-
centa was also included in this study. In contrast to bacterial
DNA, which contains MedAdo, no MedAdo was detected in
mitochondrial DNA (Table 1).
3.2. Tissue expression proﬁle of PRED28/N6AM1, a putative
N6-DNA methyltransferase
The presence of less than 103 m6A in the whole mouse gen-
ome could be biologically signiﬁcant if adenine methylation
occurs in rare speciﬁc gene regulatory elements. However, it
is diﬃcult to demonstrate the existence of a base which is
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diﬃculty can be circumvented if we consider that a pre-requi-
site for the presence of m6A is the existence of a gene coding
for a N6-DNA methyltransferase. Analysis of the human
and mouse genomes reveals the presence of PRED28/
N6AM1 on human chromosome 21, or on mouse chromosome
16, which was annotated as a putative N6-DNA methyltrans-
ferase on the basis of in silico analysis (GenBank Accession
AY456393). In order to determine the tissue expression proﬁle
of PRED28, oligonucleotide primers for the mouse PRED28
cDNA sequence deposited in GenBank (Accession
AY456393) were used to amplify PRED28 mRNA. RT-PCR
analysis of mRNA derived from several mouse tissues demon-
strates that the PRED28 gene is expressed in all the tissues
examined (Fig. 1). Interestingly, two PRED28 isoforms,
named PREDa and PREDb, were detected in mouse tissues.
The longer PRED28 isoform (PRED28a) is dominant in adult
tissues.Fig. 1. RT-PCR analysis of the tissue speciﬁc (A) and developmental
expression (B) of PRED28 in mouse. Although both PREDa and b are
ubiquitous in all tissues examined, PREDa is expressed at higher levels
than PREDb in adult tissues.
Fig. 2. Genomic organization and structure of alternatively spliced transcrip
PRED28 results in a frame shift. The two resulting alternative amino-acid seq
numbers are included.3.3. Cloning and characterization of PRED28 isoforms
To characterize these two mRNAs, molecular cloning and
DNA sequencing of the corresponding PRED28a and
PRED28b cDNA were performed. Nucleotide sequences con-
ﬁrm that the PRED28a sequence corresponded to the sequence
of the Mus musculus N6-DNA methyltransferase mRNA al-
ready deposited in GenBank under Accession AY456393,
which encodes for a 23 kDa putative protein (214 amino
acids). In contrast, the PRED28b sequence corresponded to
a new transcript variant that we deposited under Accession
AY536887. Interestingly, this alternative splicing introduces
a frame shift that generates a stop codon soon after the begin-
ning of exon VI. Thus, PREDb cDNA encodes a putative pro-
tein of 14.7 kDa (138 amino acids) (Fig. 2).
3.4. Subcellular localization of PRED28 isoforms
To gain insight into the biological function of the PRED28
protein, we analyzed the subcellular localization of the two
PRED28 isoforms. For this purpose, full-length coding se-
quences corresponding to PRED28a and PRED28b were
cloned into the eukaryotic expression vector pcDNA4/TO.
Then, C2C12 cells were transfected with either pcDNA4/PRE-
D28a or pcDNA4/PRED28b. Two stable cell lines expressing
either PRED28aC2C12-Preda or PRED28b (C2C12-Predb)
were generated. Results presented in Fig. 3 show that recombi-
nant proteins localized mainly in the nucleus.
3.5. PRED28 expression in E. coli and C2C12 cells
To investigate the ability of PRED28 to methylate adenine
residues in DNA, PRED28a and PRED28b were expressed
in the E. coli GM272 strain. GM272 is a hsdr, dam, dcm
mutant [18]. Thus, GM272 DNA contains low levels of m6A
and is therefore a useful tool to determine if PRED28
production can induce methylation of DNA. DNA fragments
encoding either PRED28a or PRED28b were placed under the
control of the araBAD promoter in the vector pBAD-TOPO
to generate pBAD/PRED28a or pBAD/PRED28b expressionts of mouse and human PRED28. The splicing of exon V in the mouse
uences encoded by the mouse exon VI are shown. GeneBank accession
Fig. 3. Expression of cloned PRED28a or PRED28b cDNA in C2C12 cells. The predominant nuclear location of recombinant PRED28 proteins
was demonstrated by immunoﬂuorescence staining of C2C12 cells transfected with either pcDNA4/PRED28a or pcDNA4/PRED28b expression
vectors. The PRED28 isoforms are labelled in green with an anti-V5 antibody (Invitrogen) and DNA is labelled in red by propidium iodide.
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inose for 1 h, immunoblotting of cell lysates reveals a protein
with a molecular mass corresponding to the PRED28 isoforms
(data not shown). Analysis of the supernatant and pellet of
lysed cells shows that following arabinose induction, most of
the synthesized protein is found in the soluble fraction (data
not shown). However, this expression does not increase the
basal level of MedAdo found in GM272 (Table 1). This resid-
ual methyl transferase activity may be due to rare dam+ rever-
tants in the cell culture, since this allele reverts at a very low
frequency (M. Marinus, personal communication). Likewise,
no MedAdo can be detected in the genomic DNA of mamma-
lian C2C12 cells that are stably transfected with expression
vectors encoding either PRED28a or PRED28b (Table 1).
Therefore, we conclude that under our assays conditions,
PRED28 has no detectable adenine DNA methyltransferase
activity.4. Discussion
In order to reinvestigate the adenine methylation status of
mammalian DNA, we developed an extremely sensitive assay
for MedAdo detection. Using this assay, which is over 100
times more sensitive than previous methods, we were unable
to identify adenine methylation in the nuclear DNA of sev-
eral mouse tissues or in human mitochondrial DNA. Hence,
if adenine methylation occurs, it would only comprise a few
hundred adenines. Alternatively, adenine methylation could
be restricted to a minor population of cells (i.e. stem cells),
or may occur during a brief period of the cell cycle. More-
over, it should be noted that the presence of a few m6A in
DNA may be critical if they are used to control the expres-
sion of a small subset of transcription factors or miRNAs.
In this regard, it is noteworthy that the artiﬁcial methylation
of adenine in several eukaryotic or viral promoters alters
their activity [24–27]. Moreover, the addition of MedAdoto cell culture medium has been reported to induce cell diﬀer-
entiation [23,28].
An alternative way to determine the presence of m6A in
mammalian genomes is to investigate the existence of a N6-
DNA methyltransferase in mammalian cells. On the basis of
bioinformatic analysis, a gene named PRED28, already anno-
tated as coding for a putative N6-DNA methyltransferase, has
been found in murine and human genomes. In humans, two
mRNA species resulting from the alternative splicing of exon
IV have been described (NM_013240 and NM_182749)
(Fig. 2). Removal of exon IV would be critical for the enzy-
matic activity of the protein since it codes for the NPPY motif
characteristic of N6-DNA methyltransferases [29] (Fig. 2).
This would suggest that the shorter human variant, named
PREDb, should be devoid of enzymatic activity. Our results
show that in mice, PREDb is generated by removal of exon
V instead of exon IV (Fig. 2). Therefore, this alternative splic-
ing does not delete the NPPY motif, but results in a frame shift
and appearance of a premature stop codon in the new reading
frame. Hence, the removal of the NPPY site in the human gene
and the generation of a frame shift introducing a premature
stop codon in the mouse gene could represent two alternative
methods to generate these isoforms. This could be an addi-
tional illustration of the role played by molecular tinkering
during the course of evolution.
Although devoid of a nuclear localization signal (NLS), both
PRED isoforms are predominantly localized to the nucleus
when expressed in C2C12 cells (Fig. 3). A likely explanation
for this nuclear localization is the small size of PRED proteins.
The estimated molecular weights (MW) of PREDa and
PREDb are 23 and 14.7 kDa, respectively. The addition of
the V5 epitope increases the MW of the fusion proteins by
4.9 kDa. The nuclear pore complex (NPC) allows slow diﬀu-
sion of proteins between 10 and 20 kDa [30]. Therefore, the
nuclear entry of the PRED proteins could be caused by passive
diﬀusion through the NPC. Interactions of these two PRED
isoforms with nuclear proteins or nucleic acids could limit their
D. Ratel et al. / FEBS Letters 580 (2006) 3179–3184 3183export from the nucleus. This could explain their preferential
localization in the nucleus Even though a N6-DNA methyl-
transferase is predicted to display nuclear localisation, expres-
sion of PRED28 isoforms in bacteria or in mammalian cells
failed to demonstrate any adenine DNA methyltransferase
activity. A possible explanation for the lack of N6-DNA meth-
yltransferase activities of PRED proteins in our methylation
assays could be the absence of unidentiﬁed cofactor(s) required
for enzymatic activity. Likewise, the tag used to identify the
recombinant PRED proteins may interfere with proper activ-
ity. Alternatively, the annotation of PRED28 as a putative
N6-DNA methyltransferase could have been erroneous. In-
deed, the NPPY motif characteristic of N6-DNA meth-
yltransferases was recently found to be shared by HemK
proteins. The HemK protein was initially misidentiﬁed and
annotated as a component of the heme biosynthetic pathway
[31]. However, it is now recognized as a bacterial N5-glutamine
methyltransferase [32]. Therefore, the possibility that PRED28
is an uncharacterized mammalian N5-glutamine methyltrans-
ferase should be considered. This point warrants further inves-
tigation because the human PRED28 gene is localized on
chromosome 21, and it may have a possible contribution to
the pathology of Down syndrome. On the basis of computer
analysis, open reading frames distinct from PRED28 which
code for several other putative N6-DNA methyltransferases
have been detected in eukaryotic genomes [33]. This raises
the possibility that in higher eukaryotes, proteins other than
PRED28 could be involved in the methylation of a small num-
ber of adenine residues, a point of crucial concern if N6-DNA
methyltransferase inhibitors are to be used as antibiotics [9,34].
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